PubRank

G L Wilcox

Author PubWeight™ 69.60‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Intrathecal morphine in mice: a new technique. Eur J Pharmacol 1980 5.99
2 Intrathecal somatostatin in cat and mouse studies on pain, motor behavior, and histopathology. Anesth Analg 1989 1.96
3 Intrathecal substance P elicits a caudally-directed biting and scratching behavior in mice. Brain Res 1981 1.61
4 Functional interactions between tumor and peripheral nerve: morphology, algogen identification, and behavioral characterization of a new murine model of cancer pain. J Neurosci 2001 1.50
5 Central and systemic morphine-induced antinociception in mice: contribution of descending serotonergic and noradrenergic pathways. J Pharmacol Exp Ther 1987 1.42
6 Differential distribution of alpha2A and alpha2C adrenergic receptor immunoreactivity in the rat spinal cord. J Neurosci 1998 1.40
7 The alpha2a adrenergic receptor subtype mediates spinal analgesia evoked by alpha2 agonists and is necessary for spinal adrenergic-opioid synergy. J Neurosci 1997 1.37
8 The role of nitric oxide in hippocampal long-term potentiation. Neuron 1992 1.33
9 Cytokine involvement in dynorphin-induced allodynia. Pain 2000 1.29
10 Spinal 5-HT3 receptor-mediated antinociception: possible release of GABA. J Neurosci 1991 1.27
11 Involvement of nitric oxide in spinally mediated hyperalgesia in the mouse. Neurosci Lett 1992 1.24
12 Functional interactions between tumor and peripheral nerve: changes in excitability and morphology of primary afferent fibers in a murine model of cancer pain. J Neurosci 2001 1.24
13 Spinal antinociceptive synergism between morphine and clonidine persists in mice made acutely or chronically tolerant to morphine. J Pharmacol Exp Ther 1999 1.23
14 Single intrathecal injections of dynorphin A or des-Tyr-dynorphins produce long-lasting allodynia in rats: blockade by MK-801 but not naloxone. Pain 1996 1.22
15 Spinally administered dynorphin A produces long-lasting allodynia: involvement of NMDA but not opioid receptors. Pain 1997 1.18
16 Agmatine reverses pain induced by inflammation, neuropathy, and spinal cord injury. Proc Natl Acad Sci U S A 2000 1.14
17 Spinal analgesic actions of the new endogenous opioid peptides endomorphin-1 and -2. Neuroreport 1997 1.04
18 Nociceptive action of excitatory amino acids in the mouse: effects of spinally administered opioids, phencyclidine and sigma agonists. J Pharmacol Exp Ther 1987 1.03
19 Pharmacological characterization of substance P-induced nociception in mice: modulation by opioid and noradrenergic agonists at the spinal level. J Pharmacol Exp Ther 1983 1.00
20 Mechanisms of induction of persistent nociception by dynorphin. J Pharmacol Exp Ther 2001 1.00
21 Mutual potentiation of antinociceptive effects of morphine and clonidine on motor and sensory responses in rat spinal cord. Brain Res 1987 1.00
22 Intrathecal substance P and somatostatin in rats: behaviors indicative of sensation. Peptides 1982 0.99
23 Nociceptive characteristics of tumor necrosis factor-alpha in naive and tumor-bearing mice. Neuroscience 2005 0.96
24 An instrument using a multiple layer Peltier device to change skin temperature rapidly. Brain Res Bull 1984 0.95
25 Functional interactions between tumor and peripheral nerve in a model of cancer pain in the mouse. Pain Med 2001 0.93
26 Acute tolerance to spinally administered morphine compares mechanistically with chronically induced morphine tolerance. J Pharmacol Exp Ther 1997 0.93
27 Tolerance to morphine analgesia: decreased multiplicative interaction between spinal and supraspinal sites. Brain Res 1984 0.93
28 A nitric oxide synthesis inhibitor (L-NAME) reduces licking behavior and Fos-labeling in the spinal cord of rats during formalin-induced inflammation. Pain 1996 0.93
29 Spinal interactions between opioid and noradrenergic agonists in mice: multiplicativity involves delta and alpha-2 receptors. J Pharmacol Exp Ther 1992 0.92
30 Agmatine improves locomotor function and reduces tissue damage following spinal cord injury. Neuroreport 2000 0.92
31 Phencyclidine selectively blocks a spinal action of N-methyl-D-aspartate in mice. Neurosci Lett 1986 0.92
32 Effects of peripheral nerve injury on alpha-2A and alpha-2C adrenergic receptor immunoreactivity in the rat spinal cord. Neuroscience 1999 0.90
33 Differential roles of 5-hydroxytryptamine1A and 5-hydroxytryptamine1B receptor subtypes in modulating spinal nociceptive transmission in mice. J Pharmacol Exp Ther 1993 0.90
34 Intrathecal serotonin in mice: analgesia and inhibition of a spinal action of substance P. Life Sci 1983 0.90
35 Excitatory amino acid receptors and nociceptive neurotransmission in rat spinal cord. Pain 1990 0.89
36 Analgesic properties of intrathecally administered heterocyclic antidepressants. Pain 1987 0.87
37 Moxonidine, a selective imidazoline/alpha(2) adrenergic receptor agonist, synergizes with morphine and deltorphin II to inhibit substance P-induced behavior in mice. Pain 2000 0.87
38 Intrathecal opioids block a spinal action of substance P in mice: functional importance of both mu- and delta-receptors. Eur J Pharmacol 1982 0.87
39 Neurogenesis in postnatal rat spinal cord: a study in primary culture. Science 1997 0.86
40 Moxonidine, a selective alpha2-adrenergic and imidazoline receptor agonist, produces spinal antinociception in mice. J Pharmacol Exp Ther 1999 0.85
41 Nitric oxide mediates Fos expression in the spinal cord induced by mechanical noxious stimulation. Neuroreport 1992 0.85
42 Baclofen, gamma-aminobutyric acidB receptors and substance P in the mouse spinal cord. J Pharmacol Exp Ther 1989 0.84
43 Moxonidine, a selective imidazoline-alpha2 -adrenergic receptor agonist, produces spinal synergistic antihyperalgesia with morphine in nerve-injured mice. Anesthesiology 2000 0.84
44 Differential effects of spinal cord lesions on narcotic and non-narcotic suppression of nociceptive reflexes: further evidence for the physiologic multiplicity of pain modulation. Brain Res 1978 0.82
45 Functional expression of adrenergic and opioid receptors in Xenopus oocytes: interaction between alpha 2- and beta 2-adrenergic receptors. Brain Res Mol Brain Res 1995 0.82
46 Analgesic synergy between opioid and α2 -adrenoceptors. Br J Pharmacol 2014 0.81
47 Muscimol, gamma-aminobutyric acidA receptors and excitatory amino acids in the mouse spinal cord. J Pharmacol Exp Ther 1989 0.81
48 Implantation of AtT-20 or genetically modified AtT-20/hENK cells in mouse spinal cord induced antinociception and opioid tolerance. J Neurosci 1994 0.80
49 Spinal plasticity of acute opioid tolerance. J Biomed Sci 2000 0.80
50 Modeling motor cortical operations by an attractor network of stochastic neurons. Biol Cybern 1996 0.79
51 Immunofluorescence analysis of antisense oligodeoxynucleotide-mediated 'knock-down' of the mouse delta opioid receptor in vitro and in vivo. Neurosci Lett 1996 0.79
52 Enhancement of NMDA-evoked neuronal activity by glycine in the rat spinal cord in vivo. Neurosci Lett 1992 0.79
53 Intrathecal 5-methoxy-N,N-dimethyltryptamine in mice modulates 5-HT1 and 5-HT3 receptors. Eur J Pharmacol 1993 0.79
54 Isobolographic analysis of analgesic interactions between intrathecally and intracerebroventricularly administered fentanyl, morphine and D-Ala2-D-Leu5-enkephalin in morphine-tolerant and nontolerant mice. J Pharmacol Exp Ther 1991 0.79
55 Synergistic behavioral effects of serotonin and tryptamine injected intrathecally in mice. Neuropharmacology 1984 0.78
56 Intradermal hypertonic saline-induced behavior as a nociceptive test in mice. Life Sci 1986 0.78
57 Modulation of N-methyl-D-aspartate and (R,S)-alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate (AMPA) responses of spinal nociceptive neurons by a N-terminal fragment of substance P. Eur J Pharmacol 1992 0.77
58 Antinociceptive effect of morphine on rat spinothalamic tract and other dorsal horn neurons. Neuroscience 1986 0.77
59 Redox manipulation of NMDA receptors in vivo: alteration of acute pain transmission and dynorphin-induced allodynia. Pain 1999 0.77
60 Ligand requirements for involvement of PKCε in synergistic analgesic interactions between spinal μ and δ opioid receptors. Br J Pharmacol 2014 0.77
61 Anti-nociceptive effect of tricyclic anti-depressants following intrathecal administration. Anesth Prog 1985 0.77
62 Effects of nitric oxide availability on responses of spinal wide dynamic range neurons to excitatory amino acids. Eur J Pharmacol 1995 0.77
63 Overlapping neural networks for multiple motor engrams. Proc Natl Acad Sci U S A 1994 0.77
64 Antinociception following implantation of AtT-20 and genetically modified AtT-20/hENK cells in rat spinal cord. J Neural Transplant Plast 1994 0.76
65 mu-opioid receptor regulates CFTR coexpressed in Xenopus oocytes in a cAMP independent manner. Brain Res Mol Brain Res 1997 0.76
66 Antinociceptive action of intrathecal neurotensin in mice. Peptides 1984 0.75
67 Antinociception following implantation of mouse B16 melanoma cells in mouse and rat spinal cord. Pain 1994 0.75
68 A renumbering method to decrease matrix banding in equations describing branched neuron-like structures. J Neurosci Methods 1996 0.75
69 An iconographic program for computer-controlled whole-cell voltage clamp experiments. J Neurosci Methods 1993 0.75
70 Tail pinch induced consummatory behaviors are associated with analgesia. Physiol Behav 1982 0.75
71 New xenograft model for assessing experimental therapy of central nervous system tumors: human glioblastoma in the intrathecal compartment of the nude mouse. Neurosurgery 1988 0.75
72 Opioid and neurokinin activities of substance P fragments and their analogs. Eur J Pharmacol 1991 0.75
73 Correlates of nociception and antinociception in dorsal root potentials in the rat. Neuropharmacology 1982 0.75
74 Cycloheximide effects on electroencephalographic and evoked responses in mice. Behav Biol 1974 0.75